TNF-α can damage the intestinal barrier function and exacerbate intestinal inflammatory response, and anti-TNF therapies are of great significance for the prevention and control of intestinal inflammatory diseases, such as inflammatory bowel disease (IBD) [50]. This evidence concerns the gene TNF and inflammatory bowel disease.